Oxytocin treats respiratory depression and reduces mortality from fentanyl and the combination of xylazine-fentanyl
Joan B. Escobar, John Wainwright, X Wang, Olga Dergacheva, Matthew W. Kay, John R. Bethea, Vivek Jain, Vsevolod Y. Polotsky, David Mendelowitz
This study shows oxytocin improves survival and respiratory function in rats with opioid-induced respiratory depression caused by fentanyl or fentanyl-xylazine combinations, outperforming naloxone in some cases.
bioRxiv · Feb 24, 2026 · PreprintPharmacology & Toxicology